Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed
22/08/2023 12:31
Incannex Healthcare Ltd IHL.AX :
* REVIEW OF IND APPLICATION FOR IHL-42X BY US FDA HAS BEEN
COMPLETED; CLINICAL TRIAL FOR PATIENTS WITH OBSTRUCTIVE SLEEP
APNOEA MAY PROCEED
* INCANNEX HEALTHCARE LTD - WILL CONTINUE START-UP PROCESS
FOR
PHASE 2/3 CLINICAL TRIAL
Source text for Eikon: ID:nGNX3C08Kx
Further company coverage: IHL.AX
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed